DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc.（DMAC）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
dmac · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$10.00
Consensus
$8.33
+50.4% upside
Low
$7.00
Median: $8 · Last Close: $5.54
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$8.33
50.4% upside
High Target
$10
80.5%
Low Target
$7
26.4%
Current Price
$5.54
as of today
Based on analyst price targets, the DMAC stock price prediction for the next 12 months ranges from $7 to $10. The consensus DMAC price forecast of $8.33 implies 50.4% upside from the current price of $5.54.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.33 | ↓ 3.77% |
1-day model range: $5.29–$5.37. Peak: $5.37 (-3.77%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -18.9% |
| 2028 | $4 | -26.6% |
| 2029 | $4 | -30.1% |
| 2030 | $4 | -31.7% |
| 2031 | — | -32.5% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DMAC · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-07-18 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-07-18 | Lake Street | Maintains | Buy→Buy |
| 2025-07-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-10-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-16 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-03-21 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on DiaMedica Therapeutics Inc. (DMAC) stock. Of the recent 21 rating actions, 1 were upgrades and 1 were downgrades. 6 analysts currently cover DMAC.
分析师推荐趋势
DMAC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$54M
↑ 681.1% YoY
Revenue Next Year
$2M
↓ 95.9% YoY
EPS This Year
$-0.78
EPS Next Year
$-0.84
↑ 6.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast DMAC EPS of $-0.78 for the current fiscal year, based on estimates from 3 analysts. The DMAC revenue forecast is $54M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
DMAC 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。DMAC 的共识目标价为 $8.33（+50.4% 上行空间），分析师共识为 Buy。
DMAC 的短期预测（明日）为 $5.33（-3.77%）。 DMAC 对 2027 年的股价预测均值为 $4。 DMAC 对 2030 年的预测区间为 $4–$4。
DiaMedica Therapeutics Inc. 在 NASDAQ 上市，代码 DMAC。DMAC 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
DMAC 预测 · 8 个问题根据 6 位华尔街分析师，DMAC 的 12 个月平均目标价为 $8.33，最高 $10.00、最低 $7.00。若有图表，中位目标价可在上方查看。相对当前价 $5.54，隐含约 +50.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.